Greg Rossi discusses the imperative to address cancer in Europe with early detection, precision medicine and equitable access. Stressing the need for urgent action to make cancer a manageable condition, highlighting disparities and the importance of innovation.
Targeted oncology treatments, enabled by biomarker testing, are leading a ‘Renaissance’ in the fight against cancer. To make full use of their potential, we need multi-stakeholder action in overcoming Europe’s testing infrastructure gaps and making testing more accessible.
